Frontlight ResearchEarly access
Neuroendocrine tumours trials in Germany
3 of 14 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleMulticenter Study for External Validation of the TB-NET Score
- Where
- Erlangen
- Age
- 18 years and over
- People
- 400 worldwide
- Run by
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
See details and how to joinNCT07903532 - No phaseTaking peopleStudy of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment
- Where
- Aschaffenburg, Berlin, Bonn, Bremen, Chemnitz, Cologne, Dresden, Erlangen, Essen, Frankfurt, Frankfurt am Main, Freiburg im Breisgau, Giesen, Goettigen, Hamburg, Heidelberg, Kiel, Leer, Leipzig, Lübeck, Ludwigsburg, Mainz, Marburg, Minden, Mülheim, München, Münster, Osnabrück, Saarbrücken, Tübingen, Westerstede, Würzburg
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- Ipsen
See details and how to joinNCT07314164 - No phaseTaking peopleRisk Factors for Neuroendocrine Neoplasms
- Where
- Nuremberg
- People
- 14,250
- Run by
- Bavarian Cancer Registry
See details and how to joinNCT06282016